Jonathan MacQuitty, PhD | Personalis Chairman

Jonathan MacQuitty, former partner at Abingworth, has more than 15 years of operational experience in senior executive roles in life science companies.
Jonathan MacQuitty, former partner at Abingworth, has more than 15 years of operational experience in life science companies, and 12 years of venture capital experience. His directorships have included Adiana, Dicerna, Entelos, Guava, Gynesonics, Iconix, Labcyte, ParAllele BioScience, Personalis, SFJ Pharma and Sunesis Pharmaceuticals. He joined Abingworth in 1999 as President and Director of the company’s US subsidiary, Abingworth Management Inc., and is based at the firm’s offices in Menlo Park, California. Before joining Abingworth he was an adviser to a Japanese venture capital firm. Between 1988 and 1997 he was CEO of GenPharm International, a biotech company in which Abingworth invested. Before this he held business development positions at Genencor and Genentech. He has served on the Board of the Biotechnology Industry Organisation (BIO). Jonathan has an MA in Chemistry from Oxford University, a PhD in Chemistry from the University of Sussex, and an MBA from Stanford University. Jonathan is now the CEO of Forty Seven, Inc, an immuno-oncology company based in Palo Alto, CA.